Phase I Study of PS-341 in Combination With 5-Fluorouracil and External Beam Radiotherapy For The Treatment Of Locally Advanced And Metastatic Rectal Cancer.
Phase of Trial: Phase I
Latest Information Update: 13 Feb 2012
At a glance
- Drugs Bortezomib; Fluorouracil
- Indications Colorectal cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 13 Feb 2012 Actual patient number (11) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Actual end date (1 Sep 2010) added as reported by ClinicalTrials.gov.